{"nct_id":"NCT00154362","title":"The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.","status":"COMPLETED","status_verified_date":"2011-11","start_date":"2003-04","start_date_type":null,"primary_completion_date":"2004-10","primary_completion_date_type":"ACTUAL","completion_date":"2004-10","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}